Wobble Genomics
PrivateLast Round
Series A
Mar 7, 2024
Total Funding Raised
$13.76M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Wobble Genomics operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Series A round in March 2024.
Wobble Genomics is a biotechnology company that specializes in long-read RNA sequencing and the discovery of novel nucleic acid biomarkers to improve cancer diagnostics and therapy selection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wobble Genomics Comparables
Compare Wobble Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alida Biosciences | 81% | |
| Alithea Genomics | 77% | |
| DirectSeq Biosciences, Inc. | 77% |
For institutional investors. Book with your work email.
Wobble Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 7, 2024 | ||||
| Seed Round | Dec 22, 2023 | ||||
| Seed | Sep 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wobble Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGF | Series A |
| Mercia Ventures | Series A |
| IQ Capital | Series A |
| Old College Capital | Series A, Seed |
| Eos Advisory | Series A, Seed |
| Mercia Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 1460% MoM, from 68 to 1.1K.
- Apr 20, 2026
Presenting new data on mRNA sequencing for ADC therapy selection at AACR Annual Meeting 2026.
For institutional investors. Book with your work email.
Wobble Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wobble Genomics's valuation, stock price, and market status.
Is Wobble Genomics a public or private company?
Wobble Genomics is a private company.
What is the current stock price of Wobble Genomics?
Wobble Genomics is a private company, so its shares have no public market price. Caplight tracks Wobble Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wobble Genomics worth (valuation)?
Valuation information for Wobble Genomics is not publicly available.
Can I buy Wobble Genomics stock?
Wobble Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wobble Genomics's last funding round?
Wobble Genomics's most recent funding round was Series A on March 7, 2024.
Who are the main investors in Wobble Genomics?
Key investors in Wobble Genomics include BGF, Mercia Ventures, Eos Advisory, Mercia Ventures.
Will Wobble Genomics IPO soon?
No public IPO plans have been announced for Wobble Genomics.
How can I track Wobble Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Wobble Genomics's shares on secondary markets.